Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3Warts 2Neurofibromatosis 1 2Neoplasms 2Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Retinoblastoma 1Retinal Neoplasms 1Port-Wine Stain 1Pancreatic Neoplasms 1Osteoma, Osteoid 1Neurofibromatoses 1Neoplasm Metastasis 1Mucositis 1Lymphedema 1Keratosis, Actinic 1Hemangioma, Capillary 1Head and Neck Neoplasms 1Eye Neoplasms 1Cholangiocarcinoma 1Carcinoma, Squamous Cell 1Bile Duct Neoplasms 1Atrophy 1

Interventions

Gemcitabine 40Cisplatin 24Capecitabine 21Fluorouracil 19Oxaliplatin 17Leucovorin 14pembrolizumab 9Irinotecan 8Radiotherapy 7Erlotinib Hydrochloride 7durvalumab 6Sorafenib 4Magnetic Resonance Spectroscopy 4Carboplatin 4trametinib 3Trastuzumab 3Photochemotherapy 3Long-Term Synaptic Depression 3Interleukin-12 Subunit p35 3Filgrastim 3Dihematoporphyrin Ether 3Dexamethasone 3Chemotherapy, Adjuvant 3trifluridine tipiracil drug combination 2tivozanib 2tislelizumab 2spartalizumab 2regorafenib 2olaparib 2dehydroftorafur 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Bile Duct Neoplasms × Lasers × Clear all
NCT01755013 2017-02-20

Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma

Weill Medical College of Cornell University

Phase 2/3 Unknown
55 enrolled
Gastrointestinal

Bile Duct Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡